• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Lannett CDMO

    Syngene International Ltd.

    CMC Pharmaceuticals

    LOTTE BIOLOGICS

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Lannett CDMO

    Syngene International Ltd.

    CMC Pharmaceuticals

    LOTTE BIOLOGICS

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    FDARA and Beyond

    In a few short years, PBOA establishes itself as a key industry resource

    Related CONTENT
    • Aurinia and Lonza Expand Manufacturing Partnership
    • DSCSA Deadline Approaches
    • FDA Releases FY 2018 GDUFA Rates
    • FDA Reauthorization Act Signed into Law
    • Senate Passes FDA Reauthorization Act
    Gil Roth, Pharma & Biopharma Outsourcing Association09.06.17
    It was around 6 p.m. on Friday, August 18 when I got word that the White House had signed H.R. 2430, the FDA Reauthorization Act (FDARA), into law. FDARA reauthorizes several major FDA user fees for new five-year periods (FY2018-22), including the Generic Drug User Fee Amendments (GDUFA). Fittingly, the news came out via Twitter, albeit not from the President’s account.

    As I scrolled through the @pboassoc timeline and read more statements about the signing, I flashed back on some of the milestones that brought us here: the afternoon in 2015 when our FDA contact e-mailed to say PBOA would be included in GDUFA II negotiations, the first negotiating session that October, the first time I blew my top (later that same month), the Saturday night in August 2016 when I “cracked the code” on a new fee model for the program, the ratification vote we held a few days later, the House and Senate subcommittee briefing visits after the election, and even back to the article I wrote for Contract Pharma back in 2013 that started this whole odyssey.

    Schoolhouse Rock’s “I’m Just a Bill” cartoon prepared me for a long wait, but I will admit that I grew a little impatient during the 366-day span from industry ratification of GDUFA II to FDARA’s enactment into law. Still, it turned out to be time well spent, as our lobbying efforts on the Hill put PBOA and our constituents on the radar.

    PBOA worked within the legislative process to protect GDUFA’s provisions from wayward amendments, holding numerous meetings with key congressional staff to explain GDUFA II’s new provisions, the funding model, and how the revised GDUFA program will help FDA and industry achieve the shared goal of improving review times and bringing more generic drugs to market faster. We were shepherded by our Washington, DC-based advocacy firm, whose staff learned our unique set of interests, lined up the right meetings for us, and kept us apprised of the key steps in the process of bringing FDARA to fruition.

    From a CMO/CDMO perspective, our work on GDUFA II established a funding structure that reduces the user fee burden on CMOs and on manufacturing facilities overall: the CMO finished dosage form (FDF) Facility Fee will drop from $258,646 in FY17 to $70,362 in FY18 (non-CMO FDF facilities will pay $211,087), even as the overall GDUFA budget grows by 53%.

    Just as important, the work we did on GDUFA established PBOA as the key resource for FDA and Congress when it comes to CMO/CDMO issues. We’ve made strong contributions to discussions on DSCSA/serialization implementation, the FDA’s Quality Metrics initiative, and the proposed OTC Monograph User Fee (OMUFA). The latter makes some of the same facility fee-derived mistakes of GDUFA I; in its initial proposal, 100% of the budget is derived from facility fees, with no carveout or exemptions for CMOs. We’ve argued to Congress that this model is regressive and may drive CMOs out of that manufacturing space, and they’ve listened, bringing us in for meetings to discuss our issues with the proposed funding model and our ideas for a fairer, more equitable structure. That sort of conversation is invaluable, and it didn’t exist for us as an industry a few short years ago.

    As we move past FDARA (until the next reauthorization cycle), PBOA is in a position to advance a more proactive agenda, bringing together the voices of the CMO/CDMO sector to develop ideas that can strengthen our industry, improve quality, and bring effective medicines to patients. We’ll be discussing our future agenda during our first annual PBOA Meeting & Conference, a members-only event held October 3-4, 2017 in Rockville, MD.

    PBOA isn’t PhRMA- or BIO-sized, but we do manage to punch above our weight, and that’s a testament to the critical role that our members play in the healthcare system.


    Gil Roth
    President, Pharma & Biopharma Outsourcing Association

    Gil Roth is the President of the Pharma & Biopharma Outsourcing Association (www.pharma-bio.org). He can be reached at gil.roth@pharma-bio.org.
    Related Searches
    • Biopharma Outsourcing
    • patients
    • quality
    • CDMO
    Suggested For You
    Aurinia and Lonza Expand Manufacturing Partnership Aurinia and Lonza Expand Manufacturing Partnership
    DSCSA Deadline Approaches DSCSA Deadline Approaches
    FDA Releases FY 2018 GDUFA Rates FDA Releases FY 2018 GDUFA Rates
    FDA Reauthorization Act Signed into Law FDA Reauthorization Act Signed into Law
    Senate Passes FDA Reauthorization Act Senate Passes FDA Reauthorization Act
    Heading to BIO 2017! Heading to BIO 2017!
    Newsmakers: Lee Karras Newsmakers: Lee Karras
    CROs & Next-Gen  Drug Development CROs & Next-Gen Drug Development
    Biomanufacturing Trends and Outlook 2017: Where Is It All Going? Biomanufacturing Trends and Outlook 2017: Where Is It All Going?
    Injectable Drug Delivery Trends Injectable Drug Delivery Trends
     Vantage Consulting is First Systems Integrator to Join PBOA Vantage Consulting is First Systems Integrator to Join PBOA
    Reality and Un-Reality:  Continuous Processing in Pharmaceutical Manufacturing Reality and Un-Reality: Continuous Processing in Pharmaceutical Manufacturing
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner
    16th Annual Contract Pharma Contracting & Outsourcing Conference & Tabletop Exhibition 16th Annual Contract Pharma Contracting & Outsourcing Conference & Tabletop Exhibition
    Whither Washington? Whither Washington?

    Related Breaking News

    • APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Aurinia and Lonza Expand Manufacturing Partnership

      Aurinia and Lonza Expand Manufacturing Partnership

      Form agreement for voclosporin manufacturing capacity.
      Contract Pharma Staff 12.16.20

    • Serialization

      DSCSA Deadline Approaches

      An expert panel will convene at Contract Pharma’s upcoming conference to discuss key serialization issues, challenges and
      Tim Wright, Editor 09.06.17

    • cGMP Manufacture | Industry News | Regulatory Affairs
      FDA Releases FY 2018 GDUFA Rates

      FDA Releases FY 2018 GDUFA Rates

      The FY 2018 fee represents a significant drop from FY17's FDF fee of $258,646
      08.28.17


    • Breaking News | cGMP Manufacture | Industry News
      FDA Reauthorization Act Signed into Law

      FDA Reauthorization Act Signed into Law

      Renews four major user fee agreements between industry and FDA through FY2022
      08.21.17

    • Breaking News | cGMP Manufacture | Drug Development | Industry News | Regulatory Affairs
      Senate Passes FDA Reauthorization Act

      Senate Passes FDA Reauthorization Act

      Aims to allow faster approval of generic drugs and modifies fee structure for various stakeholders
      08.04.17

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login